Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lazarus

Showing results (731-740 of 1,048) with videos related to

Pageof 105
Sort By:
Experimental Hematology|November 24, 1999
Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseasesO N Koç, C Peters, P Aubourg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryJ M Vose, M J Zhang, P A Rowlings, et al.
Leukemia|March 21, 2008
Allogeneic transplantation of multiple umbilical cord blood units in adults: role of pretransplant-mixed lymphocyte reaction to predict host-vs-graft rejectionL R Fanning, Y Hegerfeldt, M Tary-Lehmann, et al.
Leukemia Research|July 3, 2014
Younger adults with acute myeloid leukemia in remission for ≥ 3 years have a high likelihood of cure: The ECOG experience in over 1200 patientsJustin M Watts, Xin Victoria Wang, Mark R Litzow, et al.
American Journal of Hematology|April 21, 2020
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction modelsGouri Dharmavaram, Shufen Cao, Suchitra Sundaram, et al.
Blood Advances|November 3, 2018
Aberrant GSK3β nuclear localization promotes AML growth and drug resistanceJames J Ignatz-Hoover, Victoria Wang, Nathan M Mackowski, et al.
Blood|March 22, 2007
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remissionMartin S Tallman, Gordon W Dewald, Sharavi Gandham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2013
Prevalence of hematopoietic cell transplant survivors in the United StatesNavneet S Majhail, Li Tao, Christopher Bredeson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantationMarcelo C Pasquini, Steven Devine, Adam Mendizabal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcomaPatrick J Stiff, Manza-A Agovi, Karen H Antman, et al.
Pageof 105

Showing results (731-740 of 1,048) with videos related to

Sort By:
Pageof 105
Experimental Hematology|November 24, 1999
Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseasesO N Koç, C Peters, P Aubourg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant RegistryJ M Vose, M J Zhang, P A Rowlings, et al.
Leukemia|March 21, 2008
Allogeneic transplantation of multiple umbilical cord blood units in adults: role of pretransplant-mixed lymphocyte reaction to predict host-vs-graft rejectionL R Fanning, Y Hegerfeldt, M Tary-Lehmann, et al.
Leukemia Research|July 3, 2014
Younger adults with acute myeloid leukemia in remission for ≥ 3 years have a high likelihood of cure: The ECOG experience in over 1200 patientsJustin M Watts, Xin Victoria Wang, Mark R Litzow, et al.
American Journal of Hematology|April 21, 2020
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction modelsGouri Dharmavaram, Shufen Cao, Suchitra Sundaram, et al.
Blood Advances|November 3, 2018
Aberrant GSK3β nuclear localization promotes AML growth and drug resistanceJames J Ignatz-Hoover, Victoria Wang, Nathan M Mackowski, et al.
Blood|March 22, 2007
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remissionMartin S Tallman, Gordon W Dewald, Sharavi Gandham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2013
Prevalence of hematopoietic cell transplant survivors in the United StatesNavneet S Majhail, Li Tao, Christopher Bredeson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantationMarcelo C Pasquini, Steven Devine, Adam Mendizabal, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcomaPatrick J Stiff, Manza-A Agovi, Karen H Antman, et al.
Pageof 105